Classification and prognostic evaluation of Myelodysplastic syndromes

Seminars in Oncology

Volumn 38, Issue 5, 2011, Pages 627-634

  Cazzola, Mario ^a   Della Porta, Matteo G ^a   Travaglino, Erica ^a   Malcovati, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; CANCER GROWTH; COMORBIDITY; DISEASE CLASSIFICATION; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

COMORBIDITY; HUMANS; KAPLAN-MEIER ESTIMATE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK ASSESSMENT;

EID: 80053192528     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.04.007     Document Type: Article

References (30)

1. M. Cazzola, and L. Malcovati Myelodysplastic syndromescoping with ineffective hematopoiesis N Engl J Med 352 2005 536 538
2. S.H. Swerdlow, E. Campo, and N.L. Harris WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Lyon
3. L. Malcovati, and M. Cazzola Myelodysplastic/myeloproliferative disorders Haematologica 93 2008 4 6 (Pubitemid 351156143)
4. A. Reiter, R. Invernizzi, N.C. Cross, and M. Cazzola Molecular basis of myelodysplastic/myeloproliferative neoplasms Haematologica 94 2009 1634 1638
5. A. Tefferi, and J.W. Vardiman Myelodysplastic syndromes N Engl J Med 361 2009 1872 1885
6. G.J. Mufti, J.M. Bennett, and J. Goasguen Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts Haematologica 93 2008 1712 1717
7. D. Haase, U. Germing, and J. Schanz New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Blood 110 2007 4385 4395 (Pubitemid 351377805)
8. M.G. Della Porta, L. Malcovati, and R. Invernizzi Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome Leukemia 20 2006 549 555
9. K. Ogata, M.G. Della Porta, and L. Malcovati Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study Haematologica 94 2009 1066 1074
10. A.A. van de Loosdrecht, C. Alhan, and M.C. Bene Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes Haematologica 94 2009 1124 1134
11. M.G. Della Porta, L. Malcovati, and E. Boveri Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes J Clin Oncol 27 2009 754 762
12. J.M. Bennett, and A. Orazi Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach Haematologica 94 2009 264 268
13. J.M. Bennett, D. Catovsky, and M.T. Daniel Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199 (Pubitemid 12073508)
14. M. Cazzola Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms Haematologica 96 2011 349 352
15. J.W. Vardiman, N.L. Harris, and R.D. Brunning The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2002 2292 2302
16. R.D. Brunning, A. Orazi, and U. Germing Myelodysplastic syndromes/neoplasms, overview S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Lyon 88 93
17. L. Malcovati, M. Della Porta, and C. Pascutto Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria. A basis for clinical decision-making J Clin Oncol 23 2005 7594 7603 (Pubitemid 46291823)
18. G.F. Sanz, M.A. Sanz, and P.L. Greenberg Prognostic factors and scoring systems in myelodysplastic syndromes Haematologica 83 1998 358 368 (Pubitemid 28217858)
19. P. Greenberg, C. Cox, and M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088 (Pubitemid 27132124)
20. L. Malcovati, U. Germing, and A. Kuendgen Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes J Clin Oncol 25 2007 3503 3510 (Pubitemid 47315575)
21. L. Malcovati, M.G. Della Porta, and C. Strupp Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) Haematologica 2011 Jun 9 [Epub ahead of print]
22. H. Kantarjian, S. O'Brien, and F. Ravandi Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System Cancer 113 2008 1351 1361
23. M. Cazzola, and L. Malcovati Prognostic classification and risk assessment in myelodysplastic syndromes Hematol Oncol Clin North Am 24 2010 459 468
24. E.P. Alessandrino, M.G. Della Porta, and A. Bacigalupo WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) Blood 112 2008 895 902
25. E. Zipperer, D. Pelz, and K. Nachtkamp The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome Haematologica 94 2009 729 732
26. M.G. Della Porta, and L. Malcovati Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome Haematologica 94 2009 602 606
27. M.G. Della Porta, L. Malcovati, and C. Strupp Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome Haematologica 96 2011 441 449
28. K. Naqvi, G. Garcia-Manero, and S. Sardesai Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model J Clin Oncol 29 2011 2240 2246
29. J.F. Piccirillo, R.M. Tierney, I. Costas, L. Grove, and E.L. Spitznagel Jr Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447 (Pubitemid 38669187)
30. R. Bejar, K. Stevenson, and O. Abdel-Wahab Clinical effect of point mutations in myelodysplastic syndromes N Engl J Med 364 2011 2496 2506